Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSearches for Mounjaro wholesale are common, but the term means very different things depending on who is asking. In the licensed UK supply chain, tirzepatide moves from manufacturer to wholesaler to registered pharmacy — it is not available for individuals or unlicensed businesses to buy in bulk. As a clinician-led service with a GPhC-registered pharmacy, nume sources Mounjaro through Eli Lilly's authorised UK distribution network, which is the only legal route for a prescription-only medicine. If you have arrived here wondering whether you can purchase Mounjaro at a wholesale or trade price, the direct answer is no — not legally, and not safely outside a regulated supply chain. Mounjaro is a Prescription-Only Medicine, and clinical assessment by a registered prescriber is required before it can lawfully be dispensed to any patient.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide is manufactured by Eli Lilly and enters the UK through MHRA-licensed wholesalers, businesses holding a Wholesale Dealer's Licence (WDA(H)). From there it moves to GPhC-registered pharmacies, which can only dispense it against a valid prescription. That chain is tightly regulated at every link. There is no legitimate step in it where an individual patient, a gym, a weight-loss clinic without pharmacy registration, or an online marketplace can buy in bulk at a wholesale tirzepatide price and then pass pens on to others.
The MHRA's licensing framework exists precisely to prevent medicines drifting outside that chain. A Wholesale Dealer's Licence is not something a small operator can quietly obtain; it requires inspections, appropriate premises, qualified persons and ongoing regulatory reporting. The BNF entry for tirzepatide and the full prescribing information on the Electronic Medicines Compendium (eMC) both sit within this framework, documents that exist because the medicine is POM-controlled, not freely traded.
At nume, Mounjaro is sourced through Eli Lilly's authorised supplier relationships. Our clinical team reviews every patient individually before a prescription is issued; the pen that arrives with your DPD tracking notification has travelled an auditable path from manufacturer to your door. That is what a genuinely regulated supply looks like in practice.
One common assumption is that wholesale prices represent a legitimate shortcut, that buying closer to the manufacturer somehow bypasses the prescription requirement or cuts the cost for patients. It does not, and it cannot. The prescription requirement is set by UK law (the Human Medicines Regulations 2012), not by pricing policy. Even a fully licensed pharmaceutical wholesaler cannot dispense Mounjaro directly to a patient; that step requires a pharmacy and a prescription.
A related search pattern comes from practitioners (GPs, nurses, independent prescribers) who sometimes explore sourcing options before understanding that their clinic's pharmacy arrangements must also satisfy GPhC and MHRA requirements. If you are a healthcare professional looking at wholesale tirzepatide online, the starting point is checking whether any supplier holds a current WDA(H) and whether your own premises are set up for lawful dispensing.
The MHRA's public warnings about fake weight-loss pens are directly relevant here. When demand outstrips regulated supply, a grey and counterfeit market fills the gap. In October 2025, enforcement teams raided the first illicit UK site manufacturing fake tirzepatide pens (in Northampton) alongside wider operations that resulted in roughly 20 million doses of illegally traded weight-loss medicines, worth around £45 million, being seized across 2025. Those figures put the scale of the problem into sharp relief. The MHRA Yellow Card scheme allows anyone to report a suspected counterfeit or illegal seller, and that reporting genuinely matters.
If the underlying question behind a wholesale search is cost (how to get Mounjaro at a lower price) that is a reasonable thing to wonder about. Private treatment is not cheap, and Eli Lilly raised Mounjaro's UK list price substantially from September 2025, with the highest dose moving from around £122 to around £330 per four-week pen. Typical private prices since then have ranged roughly £149–£375 per month depending on dose and provider, as widely reported.
What that context should not do is push patients towards unverified suppliers promising trade or wholesale pricing. For a prescription medicine, the question of legitimacy comes before the question of cost. A supply with no auditable chain, no prescriber review, and no GPhC-registered pharmacy at the point of dispense is not a bargain, it is a different product with unknown contents. The MHRA's consistent message is that fake pens have been found to contain substances including insulin, which is dangerous outside clinical supervision.
You can read more about the cost landscape on our Mounjaro pricing and access page, which covers what a private prescription legitimately includes. Understanding the full picture (consultation, clinical review, genuine supply chain, aftercare) is the right framework for comparing options. Details about what regulated UK wholesale medical supplies for tirzepatide in the UK look like, and what questions to ask, are covered in a separate resource if you are approaching this from a professional rather than patient perspective.
The GPhC maintains a public register of every registered pharmacy in Great Britain, searchable by name, address or registration number. Any online pharmacy dispensing Mounjaro in the UK should appear on that register. You can verify nume's own registration (premises number 9012878) directly at the GPhC pharmacy register. If a seller cannot point you to a verifiable GPhC registration, that is reason enough to look elsewhere.
Beyond the register, the practical markers of a legitimate service are consistent: a prescriber reviews your answers before any medicine is dispensed; your identity and weight are confirmed; your GP is notified in line with GPhC guidance; and the medicine arrives in properly labelled, temperature-controlled packaging from a named courier. These are not optional extras. They are what dispensing a prescription-only medicine correctly looks like.
If you are a patient ready to explore whether Mounjaro is clinically appropriate for you, the first step is a consultation rather than a price search. Our prescribers review consultations the same day, and you can speak to our prescribers through a free consultation with no obligation. For a broader overview of how Mounjaro is sold and accessed through regulated channels in the UK, including what that process involves from a clinical and supply perspective, you can find background on how tirzepatide works and is used in regulated treatment alongside our dedicated resource on the wholesalers and distributors involved in Mounjaro's UK supply chain.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.